Mechanistic insights into lipoprotein(a): from infamous to ‘inflammous’
- 23 May 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (24), 2272-2274
- https://doi.org/10.1093/eurheartj/ehaa420
Abstract
No abstract availableFunding Information
- Austrian Science Fund
- FWF (P31458-B34)
- Center And Research InstitutE
This publication has 16 references indexed in Scilit:
- Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular diseaseNature Reviews Cardiology, 2019
- Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatmentEuropean Heart Journal, 2018
- Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering TherapiesJAMA Cardiology, 2018
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansJournal of the American College of Cardiology, 2016
- Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)Journal of Clinical Lipidology, 2015
- Lipoprotein(a): resurrected by geneticsJournal of Internal Medicine, 2012
- Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk FactorsJournal of the American College of Cardiology, 2009
- Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytesBlood, 2001
- Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in AtherogenesisJournal of the American College of Cardiology, 1999
- Apolipoprotein(a) Induces Monocyte Chemotactic Activity in Human Vascular Endothelial CellsJournal of the American College of Cardiology, 1997